We are a leading media and communications litigation team with an outstanding reputation. We act for corporates and individuals based in the UK and overseas.

Our expertise in media disputes

Our expertise is in all areas of media and communications disputes with a particular focus on English High Court litigation, including data privacy class actions.

We have the skills, expertise and depth to conduct groundbreaking, complex and high-value disputes.

 

Innovative cost arrangements

We have unrivalled experience in putting together innovative costs arrangements. The use of third party funding, after-the-event insurance and risk-sharing fee agreements enable our clients to manage risk and litigate from a position of financial strength.

Stewarts Litigate

A groundbreaking after the event (ATE) insurance facility for our commercial disputes clients.

Stewarts Litigate provides our commercial disputes clients with rapid access to comprehensive ATE insurance at pre-agreed market leading rates.

This communication has been authorised by Arthur J Gallagher Insurance Brokers Limited for the purpose of s21 of the Financial Services and Markets Act 2000

Stewarts Litigate ATE insurance facility

Meet the Media Disputes team

Our team are experts in the media sector.

We deal with matters in the UK courts and in foreign jurisdictions, as well as in relation to complaints made to UK regulators.

Emily Cox, Partner, Media Disputes - Stewarts

If you require assistance, please call us or email your enquiry.

Stewarts Private - Dispute Management

Stewarts Private is a dedicated dispute management service that helps our clients avoid, manage and resolve disputes. We provide strategic advice to assist in navigating serious, complex and challenging situations.

Stewarts Private

Covid-19: Navigating the legal challenges

Covid-19 is impacting individuals and companies around the world in an unprecedented way. The insights collected here will help you navigate the key legal issues you may be facing at this time.

Coronavirus Covid-19